Abortion drugs, also known as medical abortion or medication abortion refer to medications that are used to terminate early unwanted pregnancy. Medical abortion pills like mifepristone and misoprostol are taken orally to induce abortion. They are approved for use within the initial 63 days or nine weeks of pregnancy. Abortion drugs are being increasingly preferred over surgical methods as they can be administered privately and reduces the need for surgical instruments or anaesthesia. They provide a safe, effective and convenient option for women to end unwanted pregnancies, especially in regions where access to surgical abortion services are limited.

The global Abortion Drugs Market is estimated to be valued at US$ 3.53 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity

Rising incidences of unplanned pregnancies across both developed and developing nations is estimated to propel the demand for abortion drugs over the forecast period. According to the World Health Organization (WHO), over 60% of maternal mortalities in developing countries are linked to unsafe abortions due to lack of access to safe methods. In regions with limited access to surgical abortion services, medical abortion drugs offer a viable alternative for terminating unwanted pregnancies safely. Moreover, the stigma associated with abortions in several cultures has increased the preference for discreet medical abortion methods. Thus, growing awareness about such drugs coupled with wider availability is expected to drive robust growth of the abortion drugs market.

Porter’s Analysis
Threat of new entrants: Low capital requirements and lack of economies of scale make threat of new entrants moderate in the abortion drugs market. However, established distribution channels and loyalty towards branded products act as a deterrent.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes and intensity of competition. Buyers can negotiate on price owing to presence of numerous established players.
Bargaining power of suppliers: Large number of suppliers for raw materials in the market limits their bargaining power. Key players can switch suppliers if prices are increased substantially.
Threat of new substitutes: Threat is moderate as alternative medical/surgical procedures are available for abortion. However, demand is rising for non-invasive drug options.
Competitive rivalry: Intense due to global presence of major companies and use of differentiated marketing strategies to increase sales.

SWOT Analysis
Strength: High demand for non-invasive methods and advancement in drug delivery technologies.
Weakness: Legal restrictions and social stigma associated with abortion in certain regions.High R&D costs and stringent regulations delay market entry of new players.
Opportunity: Increasing liberalization of abortion laws worldwide.Launch of oral contraceptives to prevent unwanted pregnancies.
Threats: Availability of substitutes like contraceptive devices and alternate medical procedures. Side-effects and complications associated with drug usage.

Key Takeaways
The global Abortion Drugs Market Share  is expected to witness high growth during the forecast period owing to increasing acceptance of termination of unwanted pregnancies and rapid urbanization in developing nations.

The North America abortion drugs market holds the major share currently due to growing demand for minimally invasive procedures and widespread availability of drugs. However, Asia Pacific is likely to gain market shares fastest on back of rising medical tourism, growing awareness among women, and relaxation in legal restrictions in countries like India.

Key players operating in the abortion drugs market are BASF SE, Chang Chun Plastics Co. Ltd., Georgia Pacific Chemicals LLC, Kolon Industries Inc., Prefere Resins, Mitsui Chemicals Inc., Sumitomo Bakelite Co., Ltd, Hitachi Chemical Co. Ltd., SI Group, Inc., and Momentive Specialty Chemicals, Inc. Major players are undertaking strategic collaborations to develop new delivery mechanisms and widen geographic presence in high growth regions.

For more insights, read- https://www.ukwebwire.com/abortion-drugs-market-trends-size-and-share-analysis/